Background

On February 24th, 2022, a full-scale armed conflict broke out in Ukraine, resulting in a significant impact on the healthcare system, as well as extensive damage to the country's infrastructure. The aim of this study was to assess the challenges faced by oncologists in providing cancer care to patients.

Methods

Data were collected through a structured self-administered questionnaire administered using the Google survey tool and distributed to all participants.

Results

This was a cross-sectional study that involved 111 oncology specialists. Physicians practising in regions that were partially or temporarily occupied by the Russian army (Chernihiv and Zaporizhzhia) reported a significantly higher decline in patient numbers compared to physicians in unoccupied regions (70.0% vs 20.9%; p < 0.0001). Most physicians from both occupied and unoccupied regions reported an increase in the number of patients with advanced disease (65.0% vs. 65.9%; p = 0.735). The majority of physicians from both occupied and unoccupied regions did not see loss of information, changes in cancer treatment phases, and self-medication as a concern. The majority were satisfied with the availability of medicines and equipment.

Conclusion

This needs-based assessment is crucial for improving the quality of cancer care as it provides valuable information for designing public health interventions.

The average worldwide human life expectancy is 70 years, with a significantly higher value in Western societies. Many modern diseases are not associated with premature mortality but with a decreased quality of life in aged patients and an excessive accumulation of various toxic compounds in the human body during life. Today, scientists are especially interested in finding compounds that can help increase a healthy lifespan by detoxifying the body. Phytotherapy with specific approaches is used in alternative medicine to remove toxins from the body. Worldwide, research is conducted to identify medicinal plant-derived molecules that, with few or no side effects, may protect the liver and other organs. This review provides updated information about the detoxification process, the traditional and modern use of the most effective medicinal plants, their active metabolites as detoxifying agents, and the mechanisms and pathways involved in the detoxification process. Among medicinal plants with substantial detoxifying properties, a major part belongs to the Asteraceae family (Silybum marianum, Cynara scolymus, Arctium lappa, Helichrysum species, Inula helenium, and Taraxacum officinale). The most widely used hepatoprotective phytocomponent is silymarin, a standardized extract from the Silybum marianum seeds containing a mixture of flavonolignans. Many polysaccharides, polyphenols, and terpenoids have a detoxifying effect. Overall, scientific data on medicinal plants used in phytotherapeutic practice worldwide provides an understanding and awareness of their efficacy in detoxification.

The use of natural bioactive constituents from various food sources for anticancer purposes has become increasingly popular worldwide. Broccoli (Brassica oleracea var. italica) is on the top of the consumed vegetables by the masses. Its raw matrix contains a plethora of phytochemicals, such as glucosinolates and phenolic compounds, along with rich amounts of vitamins, and minerals. Consumption of broccoli-derived phytochemicals provides strong antioxidant effects, particularly due to its sulforaphane content, while modulating numerous molecules involved in cell cycle regulation, control of apoptosis, and tuning enzyme activity. Thus, the inclusion of broccoli in the daily diet lowers the susceptibility to developing cancers. Numerous studies have underlined the undisputable role of broccoli in the diet as a chemopreventive raw food, owing to the content in sulforaphane, an isothiocyanate produced as a result of hydrolysis of precursor glucosinolates called glucoraphanin. This review will provide evidence supporting the specific role of fresh florets and sprouts of broccoli and its key bioactive constituents in the prevention and treatment of different cancers; a number of studies carried out in the in vitro and in vivo conditions as well as clinical trials were analyzed.

Objective: Plants are an excellent source of phenolic compounds, which are among the most important antioxidant substances. The antioxidant properties of medicinal plants have prompted researchers to use them in the food, health and pharmaceutical industries.
Methods: The purpose of the present study is to investigate the antioxidant properties of the methanol extract of the medicinal plants of Salsola rigida (Salsola orientalis) and wheat. The aerial parts of these plants were dried and ground. Then plant samples were prepared using homogenized methanol. Finally, the total antioxidant capacity of the mentioned plants was evaluated using ferric iron reducing antioxidant power (FRAP).
Results: The results showed that the total antioxidant capacity for Salsola rigida and wheat was 0.77 and 2.20 Fe2+ mmol L-1, respectively. Based on our findings, wheat showed strong antioxidant activity and S. rigida showed little antioxidant capacity.
Conclusion: It is recommended to use the medicinal plants of S.rigida and wheat due to antioxidant effects against free radicals. Antioxidant medicines or supplements can be produced from the mentioned plants.

The SARS-CoV-2 virus first emerged in China in December 2019 and quickly spread worldwide. Despite the absence of a vaccination or authorized drug specifically developed to combat this infection, certain medications recommended for other diseases have shown potential effectiveness in treating COVID-19, although without definitive confirmation. This review aims to evaluate the existing literature on the efficacy of these medications against COVID-19. The review encompasses various potential treatments, including antiviral medications, anti-malaria and anti-rheumatic drugs, vaccines, corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDs), antipyretic and analgesic medicines, antiparasitic drugs, and statins. The analysis also addresses the potential benefits and drawbacks of these medications, as well as their effects on hypertension and diabetes. Although these therapies hold promise against COVID-19, further research, including suitable product production or clinical testing, is needed to establish their therapeutic efficacy.